Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.4:1
Daily Buy & Sell Volume
Transactions (392)
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
Sight Sciences, Inc. (SGHT)
Taylor Brenton — EVP, Operations&R&D
Shares
2,988
Price
$8.85
Total Value
$26.45K
Shares Held After
261,990
% of Holdings
1.1%
Sight Sciences, Inc. (SGHT)
Rodberg James — Chief Financial Officer
Shares
7,208
Price
$8.85
Total Value
$63.81K
Shares Held After
216,829
% of Holdings
3.2%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
25,260
Price
$8.85
Total Value
$223.63K
Shares Held After
639,449
% of Holdings
3.8%
VEEVA SYSTEMS INC (VEEV)
Rizzo Daniel J — EVP, Sales, Consulting,&Svcs
Shares
321
Price
$276.21
Total Value
$88.66K
Shares Held After
7,665
% of Holdings
4.0%
VEEVA SYSTEMS INC (VEEV)
Rizzo Daniel J — EVP, Sales, Consulting,&Svcs
Shares
4,520
Price
$276.53
Total Value
$1.25M
Shares Held After
7,986
% of Holdings
36.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$574.23
Total Value
$22.97K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$572.44
Total Value
$45.79K
Shares Held After
324,483
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$570.70
Total Value
$68.48K
Shares Held After
324,563
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$569.90
Total Value
$136.78K
Shares Held After
324,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$566.58
Total Value
$45.33K
Shares Held After
324,923
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$563.88
Total Value
$45.11K
Shares Held After
325,003
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.35
Total Value
$22.49K
Shares Held After
325,083
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$560.66
Total Value
$67.28K
Shares Held After
325,123
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$558.60
Total Value
$67.03K
Shares Held After
325,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$557.43
Total Value
$133.78K
Shares Held After
325,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$555.60
Total Value
$44.45K
Shares Held After
325,603
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$554.30
Total Value
$44.34K
Shares Held After
325,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$552.86
Total Value
$88.46K
Shares Held After
325,763
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
725
Price
$551.82
Total Value
$400.07K
Shares Held After
325,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
432
Price
$550.99
Total Value
$238.03K
Shares Held After
326,648
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
757
Price
$549.59
Total Value
$416.04K
Shares Held After
327,080
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$548.87
Total Value
$661.94K
Shares Held After
327,837
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,171
Price
$547.99
Total Value
$641.70K
Shares Held After
329,043
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
309
Price
$546.75
Total Value
$168.94K
Shares Held After
330,214
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$544.90
Total Value
$697.47K
Shares Held After
330,523
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,032
Price
$544.17
Total Value
$561.59K
Shares Held After
331,803
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
408
Price
$542.87
Total Value
$221.49K
Shares Held After
332,835
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$542.06
Total Value
$379.44K
Shares Held After
333,243
% of Holdings
0.2%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$41.03
Total Value
$83.46K
Shares Held After
221,388
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
627
Price
$26.33
Total Value
$16.51K
Shares Held After
20,598
% of Holdings
3.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,786
Price
$23.19
Total Value
$134.15K
Shares Held After
9,110
% of Holdings
38.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$96.72
Total Value
$1.64M
Shares Held After
180,209
% of Holdings
8.6%
American Well Corp (AMWL)
Gotlib Phyllis — President, International
Shares
6,677
Price
$13.00
Total Value
$86.80K
Shares Held After
142,504
% of Holdings
4.5%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
799
Price
$79.67
Total Value
$63.66K
Shares Held After
5,173
% of Holdings
13.4%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
2,970
Price
$78.82
Total Value
$234.10K
Shares Held After
5,972
% of Holdings
33.2%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
4,631
Price
$78.09
Total Value
$361.63K
Shares Held After
8,942
% of Holdings
34.1%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
20,000
Price
$18.47
Total Value
$369.40K
Shares Held After
16,057
% of Holdings
55.5%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
16,431
Price
$1.33
Total Value
$21.85K
Shares Held After
908,532
% of Holdings
1.8%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
370
Price
$18.96
Total Value
$7.02K
Shares Held After
56,109
% of Holdings
0.7%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
4,314
Price
$20.90
Total Value
$90.16K
Shares Held After
382,594
% of Holdings
1.1%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
12,944
Price
$20.61
Total Value
$266.75K
Shares Held After
386,908
% of Holdings
3.2%
American Well Corp (AMWL)
Zamansky Dmitry — Chief Product&Tech. Officer
Shares
8,442
Price
$13.00
Total Value
$109.75K
Shares Held After
224,178
% of Holdings
3.6%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.42
Total Value
$14.20K
Shares Held After
1,580,294
% of Holdings
0.6%
American Well Corp (AMWL)
McNeice Paul Francis — Chief Accounting Officer
Shares
653
Price
$13.00
Total Value
$8.49K
Shares Held After
9,086
% of Holdings
6.7%
American Well Corp (AMWL)
HIRSCHHORN MARK — Chief Financial Officer
Shares
4,282
Price
$13.00
Total Value
$55.67K
Shares Held After
223,906
% of Holdings
1.9%
Sight Sciences, Inc. (SGHT)
Badawi David — Director
Shares
7,797
Price
$9.05
Total Value
$70.56K
Shares Held After
1,975,075
% of Holdings
0.4%
Showing 1–50 of 392 transactions (page 1 of 8)